Skip to main content
. 2014 Nov-Dec;20(6):350–355. doi: 10.4103/1319-3767.145320

Figure 1.

Figure 1

(a) Different treatment group at 52 weeks of treatment. Serum samples were analyzed for HBV DNA levels by fluorescent quantitative PCR. Assay lower limit of detection is 103 copies/mL. (b) Reduction in serum HBV DNA levels from baseline. Data are plotted as log10 change from baseline values. LAM, lamivudine; ETV, entecavir; LDT, telbivudine; CLA, combination of lamivudine and adefovir dipivoxil